Hypertension Related Topics 
Med Page Today
JUNE 9, 2025
(MedPage Today) -- The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of hypertension in adults, including as initial treatment. This marks the first time that a triple combination.
Med Page Today
MAY 14, 2025
(MedPage Today) -- A diuretic was able to match spironolactone for blood pressure (BP) lowering in people with resistant hypertension, a small randomized trial showed. Home-measured systolic blood pressure (SBP) was similarly reduced at 12 weeks.
Med Page Today
JUNE 7, 2025
(MedPage Today) -- Hypertension kills more people than any other condition. despite spending more than $4 trillion a year on healthcare, less than half of people with hypertension have their condition controlled even to below 140/90. In the U.S.,
Science Daily - Heart Disease
MARCH 18, 2025
Women with blood pressure levels in a range considered clinically normal during pregnancy but no mid-pregnancy drop in blood pressure face an increased risk of developing hypertension in the five years after giving birth.
DAIC
MARCH 11, 2025
will establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension. Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.
Heart BMJ
JANUARY 13, 2025
Right heart failure is the most common cause of mortality in patients with pulmonary arterial hypertension. 1 This includes chronic thromboembolic pulmonary hypertension (CTEPH), which through obstruction of the pulmonary arteries increases afterload on the right ventricle (RV), ultimately resulting in RV failure.
HCPLive
JUNE 11, 2025
A panelist discusses how spironolactone is typically the first fourth medication added for resistant hypertension but has limitations in patients with kidney disease or electrolyte issues, necessitating alternative strategies like renal denervation and highlighting the need for multiple treatment approaches to avoid polypharmacy-related adherence problems. (..)
Expert insights. Personalized for you.
140 
Let's personalize your content